European drug group to require disclosing payments to doctors

Bloomberg

Drugmakers operating in Europe must disclose payments made to doctors starting in 2016 in an effort to boost transparency and make patients aware of possible conflicts of interest.

Letter
to the
Editor

Send us a letter

Have an opinion about this story? Click here to submit a Letter to the Editor, and we may publish it in print.

Recommended for You
U.S. Food and Drug Administration (FDA)
Upcoming FDA draft on pulse oximetry's racial bias draws questions
Most Popular
1
Why systems are pumping billions of dollars into outpatient care
2
Inside UnitedHealth's playbook to deny mental health coverage
3
Former CVS Health exec joins WellBe Senior Medical
4
UnitedHealth, Centene get Medicare Advantage Star Rating upgrades
5
GE Healthcare to acquire full stake in Nihon Medi-Physics